Purple Biotech Financial Flexibility Index
Purple Biotech financial flexibility index. Purple Biotech (PPBT) has a Financial Flexibility Index of -1.28x as of June 2026. Free cash flow of $-2.50 Million (operating CF $-2.50 Million minus capex $0.00) represents -1% of total liabilities ($1.95 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Purple Biotech (2013–2025)
Financial flexibility index of Purple Biotech from 2013 to 2025. Historical Financial Flexibility Index trend for Purple Biotech across 13 annual periods. Check PPBT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Purple Biotech Financial Flexibility Index by Year (2013–2025)
Purple Biotech financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Purple Biotech. For the full cash flow conversion analysis, see PPBT operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | $-5.53 Million | $-5.54 Million | $7.91 Million | ▲ +79.9% |
| 2024 | -3.48x | $-14.37 Million | $-14.37 Million | $4.13 Million | ▼ -74.8% |
| 2023 | -1.99x | $-19.92 Million | $-19.93 Million | $10.01 Million | ▲ +9.2% |
| 2022 | -2.19x | $-16.51 Million | $-16.73 Million | $7.52 Million | ▲ +26.2% |
| 2021 | -2.97x | $-15.14 Million | $-15.25 Million | $5.09 Million | ▼ -0.9% |
| 2020 | -2.95x | $-11.94 Million | $-12.09 Million | $4.05 Million | ▼ -104.0% |
| 2019 | -1.44x | $-5.57 Million | $-5.58 Million | $3.86 Million | ▲ +36.5% |
| 2018 | -2.28x | $-8.46 Million | $-8.48 Million | $3.72 Million | ▼ -47.7% |
| 2017 | -1.54x | $-8.61 Million | $-8.63 Million | $5.59 Million | ▲ +62.3% |
| 2016 | -4.09x | $-6.25 Million | $-6.26 Million | $1.53 Million | ▼ -71.4% |
| 2015 | -2.39x | $-3.30 Million | $-3.31 Million | $1.38 Million | ▲ +48.0% |
| 2014 | -4.59x | $-4.53 Million | $-4.53 Million | $986.00K | ▼ -1026.9% |
| 2013 | -0.41x | $-512.00K | $-512.00K | $1.26 Million | — |